Upgrade to SI Premium - Free Trial

GT Biopharma (GTBP)

0.48 +0.03 (6.67%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/17/25 *Est.)

Latest Headlines

Form 8-K GT Biopharma, Inc. For: Jun 08 June 12, 2026 4:31 PM - SEC Filing After CAR-T, the Next Frontier in Cancer Immunotherapy May Belong to a Different Immune Cell June 12, 2026 8:10 AM - StreetInsider Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet June 8, 2026 9:01 AM - Globe NewsWire Three Cancer Drugs Have Reached the Clinic: Inside GT Biopharma's TriKE Bet June 8, 2026 9:01 AM - StreetInsider GT Biopharma integrates AI tools to accelerate drug discovery June 1, 2026 8:04 AM - StreetInsider GT Biopharma Provides Update on Pipeline Discovery Activities from Newly Implemented AI-Based Technological Initiatives June 1, 2026 8:00 AM - StreetInsider Form 8-K GT Biopharma, Inc. For: May 20 May 22, 2026 8:01 AM - SEC Filing Form 10-Q GT Biopharma, Inc. For: Mar 31 May 15, 2026 8:01 AM - SEC Filing GT Biopharma Reports First Quarter 2026 Financial Results May 15, 2026 8:00 AM - Globe NewsWire "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies May 14, 2026 11:12 AM - StreetInsider "Cold" Solid Tumors Become the Proving Ground for a New Generation of Engager and Immune-Priming Therapies May 14, 2026 10:55 AM - Globe NewsWire A Cancer Antigen Long Thought Untouchable Is Suddenly the Hottest Target in Oncology May 14, 2026 9:15 AM - StreetInsider GT Biopharma doses first patient in GTB-5550 solid tumor trial May 14, 2026 8:30 AM - StreetInsider GT Biopharma Announces First Patient Dosed in Phase 1 Trial of GTB-5550, a B7-H3-Targeted Natural Killer (NK) Cell Engager for Solid Tumors May 14, 2026 8:30 AM - Globe NewsWire Form EFFECT GT Biopharma, Inc. May 14, 2026 6:10 AM - SEC Filing Form 424B3 GT Biopharma, Inc. May 13, 2026 5:19 PM - SEC Filing Form S-1 GT Biopharma, Inc. April 30, 2026 4:56 PM - SEC Filing RedChip's April 16 Virtual Investor Conference to Highlight Companies Driving the Next Wave of Biotech Innovation April 10, 2026 12:56 PM - StreetInsider Form 8-K GT Biopharma, Inc. For: Apr 03 April 7, 2026 12:43 PM - SEC Filing Full Article List